Myriad Genetics Inc logo

Myriad Genetics Inc

NAS:MYGN (USA)   Ordinary Shares
$ 22.93 -0.59 (-2.51%) 08:08 PM EST
At Loss
P/B:
2.82
Volume:
410.51K
Avg Vol (2M):
596.75K
Also Trade In:
Volume:
410.51K
At Loss
Avg Vol (2M):
596.75K

Business Description

Myriad Genetics Inc logo
Myriad Genetics Inc
NAICS : 325413 SIC : 2835
ISIN : US62855J1043

Share Class Description:

MYGN: Ordinary Shares
Description
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
Name Current Vs Industry Vs History
Cash-To-Debt 0.43
Equity-to-Asset 0.6
Debt-to-Equity 0.3
Debt-to-EBITDA -0.92
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.88
Distress
Grey
Safe
Beneish M-Score -3.4
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 63.08
9-Day RSI 61.98
14-Day RSI 61.53
6-1 Month Momentum % 14.49
12-1 Month Momentum % 11.72

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.27
Quick Ratio 1.15
Cash Ratio 0.41
Days Inventory 34.85
Days Sales Outstanding 54.65
Days Payable 53.86

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.4
Shareholder Yield % -3.46

Financials (Next Earnings Date:2024-02-28 Est.)

MYGN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MYGN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Myriad Genetics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 734.4
EPS (TTM) ($) -3.36
Beta 2.11
Volatility % 44.25
14-Day RSI 61.53
14-Day ATR ($) 0.991
20-Day SMA ($) 22.2675
12-1 Month Momentum % 11.72
52-Week Range ($) 13.82 - 24.21
Shares Outstanding (Mil) 89.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Myriad Genetics Inc Filings

Filing Date Document Date Form
No Filing Data

Myriad Genetics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Myriad Genetics Inc Frequently Asked Questions

What is Myriad Genetics Inc(MYGN)'s stock price today?
The current price of MYGN is $22.93. The 52 week high of MYGN is $24.21 and 52 week low is $13.82.
When is next earnings date of Myriad Genetics Inc(MYGN)?
The next earnings date of Myriad Genetics Inc(MYGN) is 2024-02-28 Est..
Does Myriad Genetics Inc(MYGN) pay dividends? If so, how much?
Myriad Genetics Inc(MYGN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1